1
|
Behuria HG, Dash S, Sahu SK. Phospholipid Scramblases: Role in Cancer Progression and Anticancer Therapeutics. Front Genet 2022; 13:875894. [PMID: 35422844 PMCID: PMC9002267 DOI: 10.3389/fgene.2022.875894] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 03/11/2022] [Indexed: 11/13/2022] Open
Abstract
Phospholipid scramblases (PLSCRs) that catalyze rapid mixing of plasma membrane lipids result in surface exposure of phosphatidyl serine (PS), a lipid normally residing to the inner plasma membrane leaflet. PS exposure provides a chemotactic eat-me signal for phagocytes resulting in non-inflammatory clearance of apoptotic cells by efferocytosis. However, metastatic tumor cells escape efferocytosis through alteration of tumor microenvironment and apoptotic signaling. Tumor cells exhibit altered membrane features, high constitutive PS exposure, low drug permeability and increased multidrug resistance through clonal evolution. PLSCRs are transcriptionally up-regulated in tumor cells leading to plasma membrane remodeling and aberrant PS exposure on cell surface. In addition, PLSCRs interact with multiple cellular components to modulate cancer progression and survival. While PLSCRs and PS exposed on tumor cells are novel drug targets, many exogenous molecules that catalyze lipid scrambling on tumor plasma membrane are potent anticancer therapeutic molecules. In this review, we provide a comprehensive analysis of scramblase mediated signaling events, membrane alteration specific to tumor development and possible therapeutic implications of scramblases and PS exposure.
Collapse
Affiliation(s)
- Himadri Gourav Behuria
- Laboratory of Molecular Membrane Biology, Department of Biotechnology, Maharaja Sriram Chandra Bhanjadeo University, Baripada, India
| | - Sabyasachi Dash
- Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States
| | - Santosh Kumar Sahu
- Laboratory of Molecular Membrane Biology, Department of Biotechnology, Maharaja Sriram Chandra Bhanjadeo University, Baripada, India
| |
Collapse
|
2
|
Ahyayauch H, García-Arribas AB, Sot J, González-Ramírez EJ, Busto JV, Monasterio BG, Jiménez-Rojo N, Contreras FX, Rendón-Ramírez A, Martin C, Alonso A, Goñi FM. Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells. Sci Rep 2018; 8:7456. [PMID: 29748552 PMCID: PMC5945622 DOI: 10.1038/s41598-018-25905-8] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2017] [Accepted: 04/19/2018] [Indexed: 01/01/2023] Open
Abstract
The mechanisms of Pb(II) toxicity have been studied in human red blood cells using confocal microscopy, immunolabeling, fluorescence-activated cell sorting and atomic force microscopy. The process follows a sequence of events, starting with calcium entry, followed by potassium release, morphological change, generation of ceramide, lipid flip-flop and finally cell lysis. Clotrimazole blocks potassium channels and the whole process is inhibited. Immunolabeling reveals the generation of ceramide-enriched domains linked to a cell morphological change, while the use of a neutral sphingomyelinase inhibitor greatly delays the process after the morphological change, and lipid flip-flop is significantly reduced. These facts point to three major checkpoints in the process: first the upstream exchange of calcium and potassium, then ceramide domain formation, and finally the downstream scramblase activation necessary for cell lysis. In addition, partial non-cytotoxic cholesterol depletion of red blood cells accelerates the process as the morphological change occurs faster. Cholesterol could have a role in modulating the properties of the ceramide-enriched domains. This work is relevant in the context of cell death, heavy metal toxicity and sphingolipid signaling.
Collapse
Affiliation(s)
- Hasna Ahyayauch
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Institut Supérieur des Professions Infirmières et des Techniques de Santé, Rabat, Morocco.,Neuroendocrinology Unit, Laboratory of Genetics, Neuroendocrinology and Biotechnology, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco
| | - Aritz B García-Arribas
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Jesús Sot
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain
| | - Emilio J González-Ramírez
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Jon V Busto
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Bingen G Monasterio
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Noemi Jiménez-Rojo
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain.,NCCR Chemical Biology, Department of Biochemistry, University of Geneva, 1211, Geneva, Switzerland
| | - F Xabier Contreras
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Adela Rendón-Ramírez
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Cesar Martin
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Alicia Alonso
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain.,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain
| | - Félix M Goñi
- Instituto Biofisika (CSIC, UPV/EHU), 48080, Bilbao, Spain. .,Departamento de Bioquímica, University of the Basque Country (UPV/EHU), 48080, Bilbao, Spain.
| |
Collapse
|